CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating Activities
Net loss	$ (37,803)	$ (91,383)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	5,376	5,438
Amortization of intangible assets	11,420	12,473
Amortization of right-of-use lease assets	2,133	2,132
Amortization of debt issuance costs		595
Deferred income tax benefit	(18)	(2)
Loss on disposal of fixed assets	11	64
Stock-based compensation	31,005	22,478
Unrealized foreign currency losses	3,883	2,911
Amortization of premium on short-term investments	(2,199)	(2,225)
Other liabilities	815	3,496
Acquired in-process R&D acquired through the issuance of common stock		5,000
Inducement expense related to exchange of convertible senior notes		17,412
Allowance for doubtful accounts	4,067	(34)
Changes in operating assets and liabilities:
Accounts receivable	(23,984)	(11,980)
Inventory	(4,399)	(15,105)
Prepaid expenses and other current assets	(919)	3,653
Accounts payable and accrued liabilities	(113)	(4,971)
Deposits and other assets	(817)	(2,191)
Net cash used in operating activities	(11,542)	(52,239)
Investing activities
Cash paid for acquisitions, net of cash acquired	(12,437)
Purchase of real estate property	(16,607)
Purchases of short-term investments	(116,765)	(91,089)
Proceeds from sales and maturities of short-term investments	94,411	101,730
Purchases of property and equipment	(3,117)	(3,117)
Proceeds from disposal of property and equipment		38
Investment in company-owned life insurance	(2,465)	(2,081)
Other investing activities	(750)
Net cash (used in) provided by investing activities	(57,730)	5,481
Financing activities
Proceeds from exercise of stock options	9,054	24,000
Proceeds from share purchases under Employee Stock Purchase Plan	2,961	2,687
Payment of employee taxes related to vested restricted stock units	(7,294)	(4,505)
Principal paid on finance lease	(526)	(423)
Net cash provided by financing activities	4,195	21,759
Effect of exchange rate changes on cash and cash equivalents	(4,635)	(1,516)
Net decrease in cash, cash equivalents and restricted cash	(69,712)	(26,515)
Cash, cash equivalents and restricted cash at beginning of period	174,359	99,323
Cash, cash equivalents and restricted cash at end of period	104,647	72,808
Supplemental disclosures of cash flow information
Taxes paid, net of refunds	511	801
Interest paid on convertible senior notes		3,953
Other interest paid	2,115	2,316
Supplemental schedule of noncash investing and financing activities
Contingent consideration acquired	7,700
Convertible senior notes exchanged for common stock, net of debt issuance costs		226,676
Purchases of property and equipment included in accounts payable and accrued liabilities	$ 590	$ 512